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INTRODUCTION 
A. Purpose and Scope 
Giarman and Flick (8), proceeding on the assumption that it should be 
possible, with natural or artificial antioxidants, to control enzymatic 
oxidation at various stages in the biotransformation of certain barbiturates 
found that various oxidation-reduction systems markedly prolong the 
duration of anesthesia induced by thiopental ("Pentothal")• It is the 
purpose of this work to attempt to define and extend the study of such 
substances. 
In view of the results of the above workers it was decided to study the 
effects of ^tocopherol along these lines, since it is known that 
^-tocopherol is a powerful antioxidant in vivo. In an attempt to eluci¬ 
date further the mechanism of action of O^-tocopherol in this regard, it 
seemed advisable to study the interaction with certain antagonistic and 
synergistic substances. 
Because of the known differences in the dependence or independence 
of action of certain barbiturates upon their rate of metabolic transformation 
this study was designed to include several pertinent barbiturates. 
Such an investigation has a two-fold objective. Its practical one 
is the hope that a non-toxic substance may be brought to light which would 
potentiate or antagonize the effect of an intravenous anesthetic agent. 
Academically it is hoped that the results of this investigation may 
eludicate the fundamental mode of action as well as the factors involved 
in the fate and distribution of the anesthetic agents in the living organism. 
Mice were used in this study as the experimental animal, although 
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in such an investigation lies in the fact that a good sampling of a 
population may be made at a relatively low cost. Furthermore in the 
mouse the relatively low variability in the loss and regaining of the 
righting reflex under the influence of a fixed anesthetic makes possible 
the observation of sharp beginning and end points for determination of 
the duration of anesthesia. 
B» Historical Background 
I, Distribution and Fate of Barbiturates 
The duration of effect of non-volatile anesthetic agents like the 
barbiturates is determined in general by their metabolic transformation 
and excretion (l). 
It is believed that the longer acting barbiturates, barbital and 
phenobarbital for example, are excreted essentially unchanged by the 
kidneys, while an ultra-short-acting barbiturate like thiopental is 
rapidly detoxified by the liver and excreted (3,4)* Shideman, Kelly and 
Adams (2) in this regard found that 90 percent sub-total hepatectomy or 
carbon tetrachloride damage to the liver in rats prolonged anesthesia 
following intravenous thiopental by as much as 800 percent. The 
implication from this work is that thiopental is an ultra-short-acting 
barbiturate simply by virtue of its relatively rapid degeneration in the 
organism. 
Kecently, Brodie and co-workers (4,5) have presented important 
evidence leading them to conclude that thiopental is only slowly degraded 
in vivo (about 10$ per hour), and that its ultra-short action is due 
chiefly to its rapid distribution from aqueous media of the body to fatty 
depots. These workers found, for example, that the plasma concentration 
of thiopental declines rapidly for 30 minutes after an intravenous 
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injection of thiopental followed by a slow, gradual decline for 24 hours. 
It is postulated that an equilibrium between plasma and tissue is 
established primarily, and that the secondary slow decline is due to the 
slow metabolism of thiopental. The highest concentrations (up to 70%) 
of thiopental were found in the fat stores of the body, leading to the 
suggestion that it is distribution into fat which regulates the duration 
of action of this agent. This mechanism has been shown to hold for 
certain other short-acting barbiturates, but not for oxygen analogues, such 
as pentobarbital (,,Nembutal,,) (4). Rather, the short action of pento¬ 
barbital, it is suggested, is due to its rapid metabolic transformation 
in the organism (5). 
Herman and Wood (6), in keeping with Brodie’s hypothesis, compared 
the amount of thiopental needed for anesthesia in a group of fat rats as 
compared to a group of lean litter mates. They found a 5 percent decrease 
in the length of anesthesia at a fixed thiopental dosage, or a 40 percent 
increase in the amount of thiopental required for a given duration of 
anesthesia in the fat group of rats. In sharp contrast, the duration of 
pentobarbital anesthesia was not influenced by the amount of body fat. 
2. Substances which Influence the Duration of Barbiturate Anesthesia 
There have been many reports in the literature concerning exogenous 
chemical substances which influence the duration of thiopental anesthesia. 
Such substances have been extremely diverse and have had no particular 
chemical property in common. 
Lamson, Grieg and Robbins (?) found that glucose and related compounds 
increased the pentobarbital anesthesia time in dogs and guinea pigs. 
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these effects with glucose, but did observe similar effects with sodium 
lactate. 
winter (9) reported that antihistamines prolong the anesthetic effect 
of hexobarbital ("Evipal") in mice. Such agents as "Pyribenzamine", 
11 Neo-Ant ergan”, and ’’Benadryl'1 were included in this study. 
Richards, Bertcher and Taylor (10) found that guinea pigs recovering 
from barbiturate anesthesia can be returned to sleep by intraperitoneal 
injections of such diverse substances as NaSCN, NaCI (15$ solution), 
M^SO^, urea, Na. cyclohexylsulfamate. Cyclic anesthesia such as the above 
could also be obtained with intracardiac injections of 0.1 c.c. to 1.0 c.c. 
of distilled water or blood. They found that resumption of sleep occurred 
at a blood barbiturate level below the level on awakening. It was suggested 
that a change in the permeability of the blood-brain barrier should be 
kept in mind as an explanation for this action. 
Wooster and Sunderman (11) found that such vasodilatory agents as 
nitroglycerin, butyl nitrite, and sodium nitrite, administered intra- 
peritoneally prolong the sleeping time induced by thiopental in mice. 
Richards, Kueter and Klatt (12) found a prolonged pentobarbital 
anesthesia time in vitamin C-d.eficient rats but no change in the anesthesia 
time of barbital and thiopental in these animals. Higgens and Mann(13) 
reported essentially the same findings in vitamin B-deficient rats. 
"Westfall (14) showed that pyruvic acid and pyruvic acid polymers 
reduced the duration of anesthesia in rabbits anesthetized with barbiturates. 
Giarman, White and Flick (15) have shown that tetraethylthiuram 
disulfide ("Antabuse”) prolonged the anesthesia time induced by intravenous 
thiopental in mice by as much as 60 fold. Graham, Tweed and Allmark (17) 
have reproduced this effect of "Antabuse" in rats. They failed, however. 
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to prevent the ’’Antabuse" effect with sodium ascorbate just as Giarnan 
and co-workers (15) failed to prevent it with "Ferro-ascorbin" (ascorbic 
acid and ferrous sulfate), 
Giarman and Flick (18) have suggested that agents which are capable 
of prolonging thiopental anesthesia may be found among compounds which 
establish oxidation-reduction systems in vivo. These workers have reported 
that two oxidation-reduction systems, ascorbic acid-dehydroascorbie acid 
and cysteine-cystine, prolong thiopental anesthesia in the mouse. The 
ascorbic acid-dehydroascorbic acid was found to be the more potent of the 
two and was found to be effective in the production of cyclic anesthesia. 
Three to six cycles of anesthesia were observed without further addition 
of thiopental, 
3. ^-tocopherol 
It is believed that -tocopherol acts as a non-specific physiological 
antioxidant, which enters into an oxidation-reduction system in vivo 
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In normal animals it has been found that -tocopherol modifies 
the metabolism of lipids and phospholipids, enhances phosphorylation 
and improves the metabolism of carbohydrates (20. In regard to the 
influence on lipid metabolism. Dam has shown that, pathological peroxi¬ 
dation occurs in the fat of vitamin E deficient chicks (21). Dam has 
indicated that this peroxidation can be returned to a normal state 
of metabolism by the administration of vitamin E and other oxidation- 
reduction substances such as methylene blue and vitamin K (22). 
^-tocopherol phosphate in vitro is not an antioxidant and possesses 
no oxidation-reduction potential (20). Engle has shown, however, that 
this ester is readily hydrolized in vivo and has the biological activity 
of the unesterified compounds, entering into the above oxidation- 
reduction system(23). 
It is conceivable, therefore, that (^-tocopherol is potentially 
capable of modifying the duration of barbiturate anesthesia because of 
these two fundamental properties: 
1. Its antioxidant property which might inhibit bio-oxidation of 
the barbiturates. 
2. Its influence on fat metabolism which suggests a possible effect 














EXPERIMENTAL METHODS AMD RESULTS 
The barbiturate used chiefly in this study was thiopental which 
is a thiobarbiturate of the following chemical formula: 
p 
HN — C / CH2-CH3 
S=C C — CH-CH2-CH2-CH3 
KM — C=0 CH3 
Giarman and Flick found that 30 mgm. of thiopental per kilogram of 
body weight produced a convenient duration of anesthesia for studies of 
this type. Therefore, this dosage was used throughout these experiments. 
A 1.5$ solution was prepared each day by dissolving 150 mgm. of the 
sodium salt of thiopental in 10 c.c. of distilled water; thus, 0.002 c.c. 
of this solution per gram of body weight yielded the desired dosage. 
The mice were held stationary for an intravenous injection by placing 
them in a 1 inch by 4 inch glass tube which had a 1 hole rubber stopper 
at one end and a notched cork at the other end to allow protrusion of the 
tail. The glass tube was attached by a clamp to a ring stand at a 45$ ar£p,e. 
The tail was prepared for injection by sponging it with xylol and flicking 
it lightly. In this manner the lateral veins were easily visable and a 
short no. 2? gauge needle could be easily inserted. 
The intravenous injections were made slowly and uniformly over a 
period of approximately 5 seconds. The volume of material injected 
intravenously was always less than 0.1 c.c. The experimental animals 
showed no ill effects from the- injections except the occasional 
production of necrotic areas at the site of the injection. 
The ^,-tocopherol phosphate solutions were prepared by dissolving a 
weighed amount of the dry material in distilled water. This solution and 
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control saline and water solutions were injected intraperitoneally 5 
minutes before the thiopental or other barbiturate was administered 
intravenously. Exceptions to this sequence of injections occurred in 
those experiments where compounds antagonistic or synergistic to 
—tocopherol were sought. 
The duration of anesthesia was measured from the end of the thio¬ 
pental or other barbiturate injection to the time when the righting 
reflex returned in the animal. Care was taken not to stimulate the 
animals unduly after the induction of anesthesia. 
All the experiments were performed on adult mice (Webster strain) 
averaging approximately 25 grams in weight. 
Experiment I. Thiopental Controls 
Several mice were given thiopental intravenously without 
premedication with every new solution of thiopental prepared. In this 
way, several controls were obtained on each experimental day. These 
data are recorded in Table I in the Appendix. The mean sleeping time 
for this population was 5.86 minutes. 
Experiment II. Dosage-response Relationship of the Influence of 
<gC-tocopherol on Thiopental Anesthesia 
Giarman and Flick have shown that certain oxidation-reduction 
systems are effective in prolonging thiopental anesthesia, e.g. 
cysteine-cystine and ascorbic acid-dehydroascorbie acid (38). It was 
expected therefore, that the agent under study in this work, 
^-tocopherol phosphate, which is known to act in vivo as an 
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Ck"tocopherol-O(“tocopheryl“hydroquinone oxidation-reduction system 
might have a similar effect. 
Solutions of sC-tocopherol phosphate in distilled water were prepared 
in the following percentages: 0,156, 0,3125, 0,625, 1,25 and 2,50, 
These solutions were administered intraperitoneally to different groups 
of mice 5 minutes before thiopental anesthesia in the following incre¬ 
mental dosages: 7,8, 15*6, 31.25, 62,5, 125 and 250 mgm. per kilogram® 
The results of this experiment are expressed graphically in Figure I, 
the raw data for which may be found in the Appendix, The augmented 
sleeping times should be contrasted with the mean sleeping time of the 
controls (Experiment I) which is 5*86 minutes® 
It may be observed from this curve that there is a distinct prolongation 
of the duration of anesthesia at the lowest dose, 7,8 mgm. per kilogram, 
which effect is augmented at a rapid rate of change in the succeeding 
higher dosage levels up to 62.5 mgn. per kilogram. The next two dosage 
levels, 125 and 250 mgjn, per kilogram, indicate a much less marked rate 
of increase in effect. 
Experiment III, The Effect of -tocopherol Acetate 
Administered Orally 
It has been shown that ©(-tocopherol phosphate does not act as an 
antioxidant and has no oxidation-reduction potential in vitro (20), 
However, this phosphate ester has the convenient property of water 
solubility. Further, Engle has shown that the esters of ©C-tocopherol 
are readily hydrolyzed to the free acid in the living organism (23), 
It seemed necessary, nevertheless, to compare the results of 
Experiment II with those arising from an experiment involving 
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-tocopherol acetate administered orally on a sub-acute dosage regime 
prior to the intravenous injection of thiopental. 
A 2% solution of (^-tocopherol was prepared by dissolving 200 mgm. 
dl-eiv-tocopheryl acetate in 10 c.c. of peanut oil. This was administered 
orally to 15 mice by means of a silver abscess cannula which was carefully 
inserted through the esophagus into the stomach. The total doses used 
were 200, 400, and 800 mgm. per kilo., divided into convenient daily 
amounts. These dosage regimes were assumed to provide persistent, high 
I 
tissue levels. 
The dosage regimes and results are presented in TableVLII of the 
Appendix. 
From the results it was apparent that dl-gV*tocopheryl acetate 
administered orally in an oily base has little or no significant effect 
on the duration of thiopental anesthesia, in marked contrast to the 
activity observed in Experiment II. Neither the dosage regime nor the 
time interval between the last oral administration of ^-tocopherol and 
the intravenous injection of thiopental exerted any influence on these 
results. 
Experiment IV. Control Material 
Richards, Bericher and Taylor (10) have reported that various 
organic and inorganic substances can cause guinea pigs to return to sleep 
following awakening from barbiturate anesthesia. By intracardial 
injection small volumes (0.1 to 1.0 c.c.) of water, blood and glucose 
were effective. The injection of these agents did not influence the 
decline of the blood barbiturate level but permitted sleep to recur 
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played a contributory role in the effect of the intraperitoneal 
injections. 
Richards reported, further, that distilled water and normal saline 
are effective in prolonging the duration of thiopental anesthesia. 
Accordingly, it seemed necessary to study as control substances 
distilled water, isotonic (0.9%) saline, and hypertonic (3/0 saline, in 
the same manner as the ^i-tocopherol was studied. 
Five adult mice were injected intraperitoneally with each of the above 
materials 5 minutes before intravenous thiopental. The volume injected 
was the same as that used for the 0^,-tocopherol injections. 
The data from this study may be found in Table IX of the Appendix. 
these 
It was observed that premedication with/substances in the same volume 
as the .^-tocopherol solutions had no effect on the duration of 
thiopental anesthesia. The duration of anesthesia following premedication 
with each of the materials was approximately equal to that observed in 
the animals receiving no premedication,, 
Experiment V. Synergism and Antagonism of 
the ^-tocopherol Effect 
A. Methionine 
It has been shown that methionine increases the anti*oxidant 
activity of '^-tocopherol by more than three fold. Since one hypothesis 
concerning the mechanism of the ^-tocopherol effect is based on its 
antifoxidant property, it seemed fruitful to study the interaction of 
methionine and $1-tocopherol on thiopental anesthesia. 
For this experiment a 5% solution of methionine was prepared by 
dissolving 500 mgm, of meonine* in 10 c,c, of distilled water. It w$s 
*Dl-Kethionine (Wyeth) 
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found that at this concentration the- material would remain in solution 
at approximately 100°F. The methionine, at a dose level of 500 mgm. 
per kilo, was injected intraperitoneally 5 minutes before the intravenous 
thiopental in the control experiment. 
The experimental animals were given 500 mgm. per kilo, of methionine 
5 minutes before the ^-tocopherol phosphate at 250 mgm. per kilo, 
which,in turn, was followed in 5 minutes by the intravenous thiopental. 
The results of these experiments are summarized in the table below. 
Number 
of animals 
Time Sequence Premedication 
sequence 
Dosage Duration of 
anesthesia 
30 0 min. thipental 30 mg./kg. 5.86 min. 





30 mg./kg. 5.5 min. 








30 mg./kg. 40.5 min. 





30 mg./kg. 30.91 min. 
In view of the results of Experiment II which indicated a dual 
mechanism of action related to dosage, it was decided to study the effect 
of methionine on lower doses of ©^-tocopherol. Animals were premedicated 
with methionine solution at dosage of 500 mgm. per kilo, prior to the 
administration of increasing doses (7.8, 15.6, 31.25 mgm, per kilo.) 
of 04-tocopherol and the standard dose of thiopental, in the same sequence 
as above, ie„; 
1. 0 time - methionine 
2, 5 minutes - oC. -tocopherol 
3.10 minutes - thiopental 
, 
. . >'* ' ' J 
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The results are summarized, below. 
Premedication Duration of 
anesthesia 
methionine 500 mg./kg. & ^-tocopherol 31.25 mg./kg. 
methionine 500 mg./kg. & ^-tocopherol 15.6 mg./kg. 




When these results are compared with those found in Experiment II 
it is observed that enhancement of the ^-tocopherol effect by methionine 
occurred only in the high dose range of ^-tocopherol. 
B. Calcium and Magnesium 
Ames and Risley (20) have shown that .^-tocopherol phosphate, acting 
as a non-specific protein inhibitor markedly inhibits several non- 
related enzyme systems in vitro, including the suecinoxidase system. It 
was shown further by these workers that excess calcium ions completely 
remove the ^-tocopherol inhibition of the suecinoxidase system. 
Moreover Brodie and coworkers (24) have indicated that an enzymatic 
oxidative mechanism operates in the living organism to break down 
thiopental into an inactive carboxylic acid end product. 
It was decided in this investigation, therefore, to study the effect 
of calcium ions on the prolongation of thiopental anesthesia, demonstrated 
in Experiment II. For this purpose a 10/ solution of calcium gluconate* 
was used. This was administered intraperitoneally at a dosage of 
approximately 1000 mgm. per kilo. It was found necessary to administer 
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this material 15 minutes before the dWtocopherol phosphate to prevent 
precipitation of the calcium complex of ^-tocopherol in the peritoneal 
cavity. 
Furthermore it is a well-known pharmacological fact that a mutual 
antagonism exists between calcium and magnesium ions in the living 
organism. In certain experiments, therefore, we endeavored to seek an 
influence of magnesium on any inhibition of the cl-tocopherol effect by 
calcium. In these experiments 100 mgm. per kilo, of magnesium sulfate 
(in 1% solution) was administered intraperitoneally 5 minutes before the 
administration of the calcium gluconate. The results are summarized below. 
Number 
of animals 
Time Sequence Premedication 
sequence 
Dosaee < Duration of 
anesthesia 
30 0 min. thiopental 30 mg./kg. 5.86 min. 
5 0 min. Ca. gluconate 1000 mg./kg. 
5 min. thiopental 30 mg./kg. 6.60 min. 
6 0 min. Mg, sulfate 100 mg./kg. 
5 min. thiopental 30 mg./kg. 6.91 min. 
5 0 min. Ca, gluconate 1000 mg./kg. 
15 min. ^-tocopherol 250 mg./kg. 
20 min. thiopental 30 mg./kg. 11.25 min. 
5 0 min. Mg, sulfate 100 mg./kg. 
15 min. 4^-tocopherol 250 mg/kg. 
20 min. thiopental 30 mg./kg. 16.61 min. 
10 0 min. Ca. gluconate 1000 mg./kg. 
15 min. Mg. sulfate 100 mg./kg. 
20 min. ^-tocopherol 250 mg./kg. 
25 min. thiopental 30 mg,/kg. 28.41 min. 
From this experiment the following may be observed: 
1, Calcium and magnesium ions per se have no significent effect 
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2. Calcium ions markedly inhibit the -tocopherol potentiation of 
thiopental anesthesia. Magnesium ions also inhibit the 
(X-tocopherol effect. 
3. Calcium and magnesium ions in the same animal antagonize each 
other so that the ^-tocopherol potentiation of thiopental 
anesthesia in that animal is the same as when -tocopherol 
alone is used. 
Experiment VI. Failure to Produce Cyclic Anesthesia 
with -tocopherol 
Levi (24) found that the administration of myanesin to dogs or 
rabbits at the time the animal was awakening from barbiturate anesthesia 
caused a brief return of anesthesia. 
Lamson, Greig and Robbins (7) reported the production of cyclic 
anesthesia in dogs using glucose and lactate. When the animals awaken¬ 
ed from an initial dose of pentobarbital, an intravenous injection of 
glucose (10 c.c. of a 50% solution) caused a return of anesthesia for 
a relatively long period of time. 
Richards, Bertcher and Taylor (10) found that in guinea pigs 
recovering from barbiturate anesthesia (thiopental, hexabarbital and 
pentobarbital) the intraperitoneal injection of various unrelated 
organic and inorganic compounds in relatively high concentration caused 
a reinduction of anesthesia. 
Giarman and Flick (18) found that in mice awakening from a 30 mgn. 
per kilo, dose of thiopental the intraperitoneal injection of ascorbic 
acid, dehydroascorbic acid the procedure could be repeated (without 
- - 
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further thiopental) producing from 3 to 6 cycles of anesthesia. 
On the basis of these findings and the ability of oC-tocopherol 
to prolong markedly thiopental anesthesia,it was decided to determine 
its ability to produce cyclic anesthesia in the mouse, 
A group of mice were injected with thiopental at the standard 
dosage of 30 mgrru per kilo, and the duration of anesthesia recorded. 
Immediately on awakening the animals received 250 mgm, per kilo, of 
^-tocopherol phosphate intraperitoneally, A second group of mice 
received 500 mgm, per kilo, intraperitoneally of ^-tocopherol 
phosphate on awakening from thiopental anesthesia. 
The re-induction of anesthesia was not accomplished in either 
group of animals, as seen in Table X of the Appendix. 
Experiment VII. The Influence of ^-tocopherol on the 
Duration of Thiopental Anesthesia in Rabbits 
Lamson and ceworkers (7)* found a marked species difference in their 
study of non-hypnotic substances which lead to cyclic anesthesia upon 
awakening from barbiturate anesthesia. The ease of re-induction of 
anesthesia and the duration of sleep was found to be greater in guinea 
pigs than in dogs, 
Richards and coworkers (12) were also able to demonstrate a difference 
between guinea pigs and rabbits in the susceptibility to the re-induction 
of barbiturate anesthesia with inorganic substances. 
Other workers in our laboratories have shown that premedication 
with ^-tocopherol before thiopental anesthesia in the dog does not 
significantly prolong the duration of anesthesia, as it does in the mouse. 
„ .to . 
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In view of these apparent species differences it was decided to 
study the effect of a^-tocopherol on the duration of thiopental anesthesia 
in the rabbit. 
Procedure: Two rabbits weighing 2.3 kilo, and 2.8 kilo were injected 
with 12.5 mgm. per kilo, of thiopental intravenously into the lateral 
ear vein. The duration of anesthesia was then recorded. 
After a lapse of 4 days they were given intravenously 25 mgm. per 
kilo, of ^-tocopherol 5 minutes before the same dosage of intravenous 
thiopental. 
Two days after Ms lip procedure was repeated using 50mgm. per kilo, 
instead of 25 mgm. per kilo, of ^-tocopherol 5 minutes before the intra¬ 
venous thiopental. 
The results of these studies are as follows: 
1. Average duration of anesthesia x>ath no premedication-14.75 minutes 
2. Average duration of anesthesia following 25 mgm. per kilo, 
of ^-tocopherol-17» minutes 
3. Average duration of anesthesia following 50 mgm. per kilo, 
of ©C-tocopherol-16,25 minutes. 
It is apparent that ©^.-tocopherol had no significant effect on the 
duration of thiopental anesthesia in the rabbit. 
Experiment VIII. The Influence of ^.-tocopherol on Duration of 
Anesthesia Induced by Other Barbiturates 
Brodie and co-workers (4,5) have shown that thiopental is oxidized 
slowly in the living organism and is excreted as a carboxylic acid at 
a rate of 10$ per hour. He postulates that its ultra-short action is 
_ _ 
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dependent on its rapid localization in the fat stores of the body. He 
could demonstrate this same fat localization for certain thio-barbiturates 
(Surital and Kenithol). 
The tissue distribution of pentobarbital was demonstrated as being 
equal in fat and other tissues. Therefore it was postulated that the 
duration of action of pentobarbital is largely dependent on its rate of 
metabolism. 
In the light of these differences in the relative dependence of 
duration of action upon fat distribution and rate of metabolism, it was 
decided to study the effect of -tocopherol on certain other barbiturates. 
The procedure of this experiment was as follows: 
A, Hexobarbital (Evipal) 
A 2.5^ solution of hexobarbital was prepared and administered 
intravenously at a dosage-of 50 mgm. per kilo, in a manner identical 
with that used in the thiopental study, 
,^-tocopherol (dosage 250 mgm. per kilo.) was administered 5 minutes 
before the intravenous hexobarbital in the experimental animals. Sleep 
was immediate in control as well as experimental animals. 
B, Secobarbital (Seconal) 
A 5«Q$ solution of secobarbital (Seconal) was prepared and administered 
intravenously at 25 mgm. per kilo. The experimental animals were given 
-tocopherol at 250 mgm. per kilo, as above. 
It was interesting that anesthesia in the control animals was 
preceded by 30 to 90 seconds of hyperactivity and in three cases failure 
to achieve anesthesia was observed. In contrast, the animals premedicated 
with ©^-tocopherol were unconscious instantaneously following the 
completion of the secobarbital injection. 
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C. Pentobarbital (Nembutal) 
A 3% solution of pentobarbital was prepared and administered at a 
dose of 30 mgm. per kilo. The experimental animals were premedicated 
with 250 mgm. per kilo. ofo<-tocopherol intraperitoneally, as above. 
Again a sharp contrast in the onset of anesthesia was noted in the control 
and the experimental animals as in the secobarbital experiment. 
The results of these experiments are summarized in graph form in 
Figure IL The raw data are recorded in the Appendix. It is apparent that 
the effect of ^-tocopherol on the duration of pentobarbital anesthesia 
is equivalent to its effect on thiopental anesthesia. The same is time 
for secobarbital but curiously the effect is not apparent with hexo- 
barbital. 
D. Dosage-response Relationship of the Influence of ^-tocopherol 
on Pentobarbital Anesthesia 
In view of the results of Experiment II which indicated a dual 
mechanism of action of thiopental related to dosage of ^-tocopherol, 
it was decided to determine whether a similar dual mechanism might hold 
for pentobarbital. Therefore it was necessary to study the effect of 
lower doses of ^-tocopherol on pentobarbital anesthesia. 
The following procedure was used in these experiments: 
Groups of animals were premedicated with increasing doses (7*8, 
15*6, 31*25, 62.5 and 1.25 mgm. per kilo.) of ^-tocopherol 5 minutes 
before the standard dose (30 mgm. per kilo.) of pentobarbital. 
The results of this experiment in graph form produced a dosage- 
response curve nearly identical with the dosage-response curve for 
thiopental in Figure I. 
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It was noted that there was an inverse relationship between the 
dose of ^f-tocopherol and the lag observed between completion of the 
injection of pentobarbital and the onset of anesthesia. 
INFLUENCE OF oi-TOCOPHEPOl PHOSPHATE 
OH BAP BITS RATE ANESTHESIA 
(IN MICE) 
] 5 MIN. AFTER d-TOCOPHEROL 
C250MG./KG. IP) 










The data presented here indicate clearly that €(-tocopherol 
prolongs the duration of thiopental anesthesia. While such a pheno¬ 
menon has been observed before with other oxidation-reduction compounds 
very few suggestions as to the mechanism of this effect have been 
presented. Several possibilities for explaining the Ot -tocopherol 
effect may be considered. 
1. ^-tocopherol, by virtue of its antioxidant property, can 
inhibit the biological oxidation of barbiturates thereby prolonging their 
action. 
2. ^-tocopherol may influence the distribution of the barbiturates, 
altering particularly the distribution equilibrium between the aqueous 
and fat compartments of the body. 
a. Possible effect on the permeability of the blood-brain 
barrier, 
b. Possible influence on transfer of barbiturates between 
extracellular fluid and the brain cells. 
3® dC -tocopherol may antagonize the barbiturate at the enzymic 
site of anesthesia. 
4. Miscellaneous mechanisms. 
It has been shown by Brodie and others that the barbiturates undergo 
metabolic transfer in the body by way of side-chain oxidation. It is 
believed that this oxidation process goes through a succession of alcohol, 
aldehyde, and is finally excreted as a carboxylic acid. It is 
conceivable therefore that an antioxidant material introduced at any point 
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in this metabolic sequence could prolong the existence of the unchanged 
drug or one or more of the potentially active intermediate compounds 
with a resulting increase in the duration of anesthesia. 
Our finding, using several pertinent barbiturates, have not given us 
any direct evidence that this indeed is the mechanism of action. Indirect 
evidence is found, however, in the fact that anesthesia produced by 
pentobarbital is prolonged by -tocopherol in a manner similar to 
thiopental. The relative dependence of the duration of action of pento¬ 
barbital on its rate of metallic oxidation has been demonstrated by 
Maynert and Van Dyke (25) and Brodie et al. (4)* Another point of evidence 
that 9C-tocopherol acts as a blocking agent at some point in the oxidation 
of the barbiturates is the fact the methionine, which is known to 
enhance the antioxidant activity of -tocopherol, acts in a synergistic 
manner with CH-tocopherol in prolonging thiopental anesthesia. It would 
seem, therefore, that a study of the influence of ^-tocopherol on the 
rate of metabolic oxidation of those barbiturates known to be largely 
dependent upon this oxidation for their duration of action, would be an 
interesting continuation of this study. 
The demonstration by Brodie that the thiobarbiturates are rapidly 
distributed into the fat stores of the body and the postulation that 
their ultra-short action is dependent upon this distribution brings to 
mind the possibility that ^-tocopherol may alter distribution of these 
barbiturates. This possibility is even more attractive when one considers 
the property of ^-tocopherol of influencing the metabolism of lipids and 
phospholipids (26). In addition, Dam has demonstrated that the 
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pat hologic peroxidation of lipids that occurs in vitamin E defficient 
rats can be returned to nonnal withQ(-tocopherol, another indication 
of a direct relationship between Ot-tocopherol and fat metabolism. 
It is interesting to postulate that ^-tocopherol, in a manner 
unknown in our present state of knowledge, may alter the metabolism of 
fat so that the barbiturate agent is maintained in a higher concentration 
in the more effective aqueous compartment of the body® 
The biphasic curve obtained from the dosage-response relationship 
of the influence of c£ -tocopherol on the duration of thiopental anesthesia 
could be interpreted to indicate a dual mechanism of action for 
Q^-tocopherol, one acting at the lower dosages, below 31 mgm. per kilo., 
and the other being more effective at the higher dosages. There is no 
direct evidence, however, that either is a distribution effect; although 
one might well be such an effect, while the other might be concerned with 
transformation of the drug as argued above® 
As mentioned earlier, Brodie has demonstrated that the oxygen 
analogue of thiopental, i.e® pentobarbital, is not localized in the fat 
stores and its duration of action is probably not dependent on this 
factor. We xvere able to demonstrate, however,thet lie effect by O^-tocopherol 
on the duration of pentobarbital anesthesia was equivalent to its effect 
on thiopental anesthesia. Using pentobarbital in our studiescn dosage 
effect with ^-tocopherol, we obtained a biphasic curve quite similar to 
that obtained when thiopental was used. One is further encouraged to 
consider a dual mechanism of action for OC-tocopherol, one on the metabolism 
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Another mechanism concerned with altered distribution which would 
influence the duration of anesthesia is referable to changes in permeability 
of the blood-brain barrier. This barrier is constituted by the walls of 
capillaries throughout the substance of the brain and it is easily under¬ 
stood that any change in the permeability characteristics of this diffusion 
barrier would affect the quantity of barbiturate entering the brain cell 
and therefore the duration of action of the barbiturate. -tocopherol 
may be implicated as inducing an effect on permeability since it has 
been demonstrated by Dessert and Miller (28) to inhibit hyaluronidase 
which is in turn reported by Duron-Reynals (29) to affect the permeability 
of the vascular system. An even more fundamental distribution relation¬ 
ship is that found between the cerebral extracellular solution and the 
brain substance itself. Research on this aspect of the mechanism of 
OC-tocopherol on barbiturate action is non-existant and any investigation 
would be of prime importance. 
In any evaluation of ^-tocopherol1 s effect on the enzyme systems 
involved in barbiturate anesthesia one must discuss its possible action 
in each of the theories concerning the cellular activity of barbiturates 
in the brain, 
Govier and Gibbons (35) in studying the effect of pentobarbital on 
pyruvic acid metabolism in brain tissue found that barbiturates blocked 
the oxidative reactions of pyruvate. These workers demonstrated further 
that this blocking of oxidation of pyruvate acted as a barrier to 
acetylcholine synthesis with a resulting lack of activity at the neural 
junction. 
Ames and Risely (20) have shown evidence that a marked decrease in 












Furthermore Torda and Wolff (31) have shown that ^-tocopherol in very 
low concentrations is able to stimulate acetylcholine synthesis. All 
of these studies imply a close association between ^.-tocopherol and 
acetylcholine synthesis® 
Another widely accepted theory is that the barbiturates in some 
manner inhibit the activity of the respiratory enzymes in the brain 
and thereby delay the utilization of energy released by the oxidation of 
glucose. This inhibition is thought to occur in the production of high 
energy phosphate bonds in the D.P.N.(diphosphopyridlne nucleotide) system. 
Succinoxidase is a necessary enzyme in this transfer of energy. In this 
regard Ames and Risely (20) have shown that ^.-tocopherol inhibits the 
succinoxidase system® 
OC-tocopherol has also been shown to reduce markedly the activity 
of D.P.N.-ase (32). Since calcium ions are known to be necessary for the 
activity of the D.P.N.-ase system the mechanism of action of the 
^.-tocopherol in this regard may be the reduction of the calcium ion 
concentration by the formation of an insoluble calcium compound* thus 
indirectly inactivating the D.P.N.-ase system. 
This calcium antagonism of ^.-tocopherol was evident in our experiments. 
The prolonged duration of thiopental anesthesia following eC -tocopherol 
was nearly completely removed by the addition of excess calcium ions in 
the form of calcium gluconate. This action of calcium to reverse the 
effect of o^-tocopherol upon thiopental anesthesia could be antagonized 
by the addition of magnesium ions* as expected. 
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While it seems probable that ,oC-tocopherol is involved in these 
enzyme systems it is apparent that this action of ^-tocopherol would 
tend to protect the enzymes from inactivation and should therefore antagonize 
rather than prolong the action of the barbiturate. Thus, it is not possible 
at this stage of our knowledge to implicate the effect of OC “-tocopherol 
on barbiturate anesthesia by this mechanism. 
It has been suggested by other workers, including Eichards (10), that 
the hypertonicity of the various substances which influence barbiturate 
anesthesia alters the vascular dynamics of the organism resulting in a 
prolongation of anesthesia. Our negative results with normal saline, 
hypertonic saline, and distilled water, given in a manner similar to 
C^-tocopherol, would tend to discount this effect. 
Another suggestion has been that these materials stimulate a release 
of epinephrine in the organism which may be responsible for the prolongation 
of anesthesia (34). Our work did not include an investigation of this 
aspect of the problem. 
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Anesthesia produced in adult white mice by thiopental at a dosage 
of 30 mgm. per kilo, produced an average sleeping time of 5.$6 minutes. 
It was demonstrated that premedication with OC-tocopherol intra- 
peritoneally at low dosages markedly prolongs this sleeping time. The 
dosage-response curve of this study indicates the possibility of a dual 
mechanism of action for -tocopherol, one predominating at low doses up 
to 35 mgpi. per kilo, and another at the higher doses. Maximum effects 
occurred at 250 mgm. per kilo, of Ok-tocopherol with a six-fold prolong¬ 
ation of anesthesia. 
Control material (distilled water, normal saline and hypertonic 
saline) in equivalent doses were without effect on the duration of 
thiopental anesthesia, 
Ok -tocopherol acetate administered orally to mice in high doses had 
no effect on the duration of thiopental anesthesia. 
In rabbits, intravenous ■QC-tocopherol had no effect on thiopental 
anesthesia. 
The effect of materials known to be antagonistic (calcium gluconate) 
and synergistic (methionine) with sC-tocopherol was studied. 
Finally the effect of CX-tocopherol on other short-acting barbiturates 
was studied. At a dosage of 250 mgm* per kilo, of CX-tocopherol, seco¬ 
barbital and pentobarbital were prolonged about seven-fold, Hexo- 
barbital anesthesia was not significently prolonged. 
The dosage-response relationship of the influence of Ok”^000?*1181*0! 
on the duration of pentobarbital anesthesia was investigated and was 
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found to produce a curve similar to that found with thiopental anesthesia. 
Several possible mechanisms for this effect of OC-tocopherol on 





Experiment I. Thiopental Controls 
Duration of anesthesia in control mice using 30 mgm. per kilo, of 
thiopental in a 1.5$ solution without premedication. These controls were 
done at intervals from October 1951 through June 1952, 
Table I 
Mouse Weight Duration of 
no.__in grams __anesthesia in minutes 
lo 26 4.58 
2. 27 1.16 
3, 27.5 7.75 
4. 28 7.83 
5, 24 8.50 
6. 32 3.75 
7. 29 4.16 
8. 31 7.25 
9. 26 5.16 
10. 31 4.33 
11. 24 10.50 
12. 23 7.00 
13. 28 11.75 
14. 23.5 6.75 
15. 24 4.25 
16. 27 6.58 
17. 32 7.08 
18. 25 8.58 
19. 32.5 5.16 
20. 32 4.16 
21, 30 4.75 
22. 34 4.83 
23. 33 3.50 
24. 27 4.16 
25. 39 6.08 
26. 30 5.50 
27. 24 3.75 
28. 22 7.75 
29. 31 4.83 
30. 26 4.41 
Average duration of anesthesia: S,86 minutes 
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Experiment II. Dosage-response Relationship of the Influence 
of c( -tocopherol on Thiopental Anesthesia, 
(30 mgm. per kilo.) 
Part 1. 7.8 mgm. per kilo, of -tocopherol phosphate 
0.005 c.c. per gram of body weight of a 0.156% solution 
Table II 
Mouse Weight Duration of 
no._in grams ___ anesthesia in minutes 
1. 32 6.33 
2. 27 5.83 
3. 28 11.50 
4. 24 12.75 
5. 25 7.00 
Average duration of anesthesia: 8.68 minutes 
Part 2. 15.6 mgm. per kilo of^ -tocopherol phosphate 
0.01 c.c. per gram of body weight of a 0.156% solution 
Table III 
Mouse Weight Duration of 
no. _in grams____ anesthesia in minutes 
1. 29 11.50 
2. 22 5.25 
3. 23 13.75 
4. 32 19.00 
5. 23 18.75 
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Part 3. 31,25 mgm. per kilo, of ^ -tocopherol phosphate 
0.01 c.c. per gram of body weight of a 0.3125$ solution 
Table IV 
Mouse Weight Duration of 
no._1 in grams__anesthesia in minutes 
1. 30 13.00 
2. 34 33.50 
3. 32 27.16 
4. 31 9.08 
5. 31 24.75 
6. 26 25.25 
7. 27 17.16 
8. 24 31.25 
9. 26 37.00 
Average duration of anesthesia: 24.24 minutes 
Part 4. 62.50 mgn. per kilo, of €£ -tocopherol phosphate 
0.01 c.c. per gram of body weight of 0.625$ solution 
Table V 
Mouse Weight Duration of 
no. _in grams _anesthesia in minutes 
1. 28 25.50 
2. 30 24.00 
3. 27 23.75 
4. 28 36.25 
5. 27 8.00 
6. 25 21.66 
7. 22 61.66 
8. 26 9.50 
9. 32 26.20 
Average duration of anesthesia: 26.36 minutes 
_ 










■fXS * . ' 
• 






Part 5. 125.0 mgm. per kilo, of ^ -tocopherol phosphate 







anesthesia in minutes 
1. 24 17.50 
2. 32 30.00 
3. 18 18.00 
4. 24 11.75 
5. 30 27.50 
6. 24 49.16 
7. 23 36.66 
8. 26 41.50 
9. 37 16.86 
10. 34 16.33 




250.0 mgm. per 
0.01 c.c. per 
Weight 
in grams 
kilo, of -tocopherol phosphate 
gram of body weight of 2.5$ solution 
Table VII 
Duration of 
anesthesia in minutes 
1. 27 33.25 
2. 26 25.50 
3. 25 20.13 
4. 27 18.75 
5. 25 26.16 
6. 29 30.66 
7. 35 35.16 
8. 34 45.83 
9. 30 33.00 
10. 30 53.50 
11. 29 32.00 
12. 30 36.00 
13. 28 14.00 
14. 35 23.33 
15. 30 36.50 
Average duration of anesthesia: 30.91 minutes 
- . 










Experiment III. The Effect of -tocopherol Acetate 
Administered Orally 
2.0% solution of dl- 0( -tocopherol acetate in peanut oil was admin¬ 
istered orally in the following dosages and time sequence before 








Total Time since last Thiopental 
Dosage 100 mg./kg.dosage 
Duration 
of anesth, 
1. 26 100 mg/kg. q.d.x2 200 mg/kg. 3 hrs. 30 mg/kg. 1.58 
2. 28 100 mg/kg q. d. x2 200 mg/kg. 3 hrs. 30 mg/kg 12.37 
3« 29 100 mg/kg q.d.x4 400 mg/kg 2 hrs. 30 mg/kg 7.88 
4o 29.5 100 mg/kg q.d.x4 400 mg/kg 2 hrs. 30 mg/kg 7.91 
5. 30 100 mg/kg q.d.x4 400 mg/kg 2 hrs. 30 mg/kg 5.83 
6. 25 100 mg/kg q,d.x4 400 mg/kg 2< ►5 hrs. 30 mg/kg 6.13 
7. 29 100 mg/kg q.d.x4 400 mg/kg 2, ►5 hrs. 30 mg/kg 6.71 
8. 24 100 mg/kg q.d.x4 400 mg/kg 3 hrs. 30 mg/kg 5.31 
9. 26 100 mg/kg q.d.x4 400 mg/kg 3 hrs. 30 mg/kg 5.65 
10. 25 100 mg/kg q.d.x4 400 mg/kg 3. ,5 hrs. 30 mg/kg 4.83 
11. 32 200 mg/kg q.d.x4 800 mg/kg 1 hr. 30 mg/kg 3.50 
12. 34 200 mg/kg q.d.x4 800 mg/kg 1 hr. 30 mg/kg 5.75 
13. 30 200 mg/kg q.d.x4 800 mg/kg 1, .5 hr. 30 mg/kg 2.00 
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Experiment IVa Control Material 
Distilled water, isotonic (0.9%)saline and hypertonic (3%) saline 
were administered intraperitoneally 5 minutes prior to 30 mgm. per kilo, 
of thiopental intravenously. 
Table IX 
Mouse Weight Premedication Duration of 
no. in grams _anesthesia in minutes 
1. 30 ,30 c.c. dist.IfpO 5.00 
2. 37 .37 2.75 
3. 28 ,28 " 4,25 
4. 32 ,32 » 4.58 
5. 27 .2 ? " 3.50 
Average duration of anesthesia: 4,02 
1. 30.5 ,30 c.c, isot.saline 4.58 
2. 22 .22 11 7.25 
3. 28 ,28 " 8.16 
4. 30 ,30 4.00 
5. 32 ,32 » 4.83 
Average duration of anesthesia: 5,76 
1. 23 .30 c.c, 3% saline 8.75 
2. 28 .30 " 4.33 
3® 29 .30 " 5.75 
4. 30 .30 " 4.66 
5. 32 .32 » 5.25 













Experiment VI, Failure to Produce Cyclic Anesthesia 
with Cl -tocopherol 
Effect of 6^, -tocopherol in dosages of 250 and 500 mgm. per kilo, 
intraperitoneally in the production of cyclic anesthesia using 
thiopental at 30 mgm. per kilo. 
Table X 
Mouse Weight Dosage Duration of Dosage Duration of 
no. in grams thiopental anesthesia in min. -tocopherol reinduction 
1. 35 30 mg./kg. 6. — 250 mg./kg. — 0 
2. 32 Tl 4.75 n — 0 
3o 30 II 7.75 — 11 — 0 
4. 32 !1 3.25 — 500 mg./kg. ~ 0 
5* 31 tl 11.50 — ii — 0 






Experiment VIII. The Influence of ©l -tocopherol on Duration of 
Anesthesia Induced by other Barbiturates 
Part 1. Pentobarbital (Nembutal) 
a. Duration of anesthesia using 30 mgm. per kilo, of pento¬ 







anesthesia in minutes 
1. 30' 0 
2. 23 0 
3. 27 0 
4. 23 4.25 
5. 32 6.75 
6. 25 0 
7. 23 1.50 
8, 24 2.75 
9. 21 0 
10. 20 0 
Average duration of anesthesia: 3,81 minutes 
b, 30 mgm. per kilo, of pentobarbital intravenously; 
premedication—250 mgn. per kilo. ©Sy -tocopherol intraperitoneally 
Table XII 
Mouse Weight Duration of 
no. in grams anesthesia in minutes 
1, 32 18.50 
2. 34 38.00 
3. 36 32.50 
4. 23 42.00 
5. 24 35.00 
6. 29 41.00 
7. 23 15.00 
8. 28 41.50 
9. 29 31.00 
10. 26 16,00 
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Part 2. Secobarbital (Seconal) 
a. Duration of anesthesia using 25 mga. per kilo, of secobarbital 
intravenously without premedication 
Table XIII 
Mouse Weight Duration of 
no. _ in grams_ anesthesia in minutes 
1. 22 7.50 
2. 23 5.75 
3. 20 0 
4. 31 5.75 
5. 36 0 
6. 33 3,50 
7. 34 4.50 
8. 28 3.75 
9. 33 2.25 
10. 23 0 
Average duration of anesthesia: 4.7I minutes 
b. 25 mgn. per kilo, of secobarbital intravenously; 
premedication—250 mgjn. per kilo„©£ -tocopherol intraperitoneally 
Table XIV 
Mouse Weight Duration of 
no. _ in grams anesthesia in minutes 
1. 30 38.00 
2. 35 36.50 
3. 35.5 54.75 
4. 35 22.25 
5. 25 23.50 
6. 31 27.50 
7. 36 24.25 
8. 32 44.00 
9. 22 25.50 
10. 36 35.50 
11. 33 29.50 











Part. 3. Hexobarbital (Evipal) 
a. Duration of anesthesia using 50 mgm. per kilo, of hexo¬ 







anesthesia in minutes 
1. 31 8.50 
2. 30 3.33 
3. 29 14.75 
4. 31 15.25 
5. 30 6.16 
6. 37 6.25 
7. 21 6.50 
8. 27 7.25 
9. 25 4.16 
10. 26 6.50 
Average duration of anesthesia: 7.87 minutes 
Mouse 
no. 
b. 50 mgm. per kilo, of hexobarbital intravenously! 
premedication—250 mgpi. per kilo ^-tocopherol intraperitoneally 
Table XVI 
Weight Duration of 
in grams anesthesia in minutes 
1. 31 8.75 
2. 29 11.16 
3. 38 21.50 
4. 25 9.83 
5. 23 22.25 
6. 21 10.08 
7. 23 5.25 
8. 24 12.50 
9. 22 6.25 
10. 25 17.00 
Average duration of anesthesia: 12.45 minutes 
♦ 
■ 
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Part 4* Do sage--response relationship of the influence of -tocopherol 
on pentobarbital anesthesia 
a. 7*8 mgm. per kilo-tocopherol phosphate 







anesthesia in minutes 
1. 34 7.25 
2. 35 9.50 
3. 31 0, 
4. 32 4,00 
5. 34 14.75 
Average duration of anesthesia: 7,10minutes 
Mouse 
no. 
b. 15.6 mgm. per kilo.'^.-tocopherol phosphate 
0.01 c.c. per gram of body weight of a 0.156$ solution 
Table XVIII 
Weight Duration of 
in grams anesthesia in minutes 
1. 24 27.00 
2. 23 0.0 
3. 28 25.50 
4. 27 16.25 
5. 25 23.25 
Average duration of anesthesias 18,4 minutes 
c» 31.25 mgn. per kilo. & -tocopherol phosphate 
0.01 c.c, per gram of body weight of a 0.3125$ solution 
Table XIX 
Mouse Weight in grams Duration of 
no,__ _ anesthesia in minutes 
1. 25.5 40.30 
2. 28 34.00 
3. 24 45.75 
4. 26.5 30.25 
5. 23 17.50 
Average duration of anesthesia: 33.60 minutes 

-41- 
d, 62.5 mgm. per kilcu 0^ -tocopherol phosphate 
0.005 c.c. per gram of body weight of a 1.25$ solution 
Table XX 
Mouse Weight Duration of 
no. _ in grams _ anesthesia in minutes 
1. 23 35.25 
2. 24 41.50 
3. 23 23.50 
4. 24 14.75 
5. 27 31.25 
Average duration of anesthesia: 29.25 minutes 
e. 125 mgm. per kilo, dC. -tocopherol phosphate 
0.01 c.c. per gram of body weight of a 1.25$ solution 
Table XXI 
Mouse Weight Duration of 
no. _ in grams anesthesia in minutes 
1. 22 17.75 
2. 22 26.00 
3. 24 35.00 
4. 24 37.50 
5. 22.5 21.50 
Average duration of anesthesia: 27.55 minutes 
f. 250 mgm. per kilo.^ -tocopherol phosphate 






































Average duration of anesthesia: 31.05 minutes 
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